Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antiviral quinolinecarboxylic acid compounds reported by Sankyo

Aug. 26, 1999

German lab synthesizes new series of oxazolidinones

Aug. 26, 1999

MacroChem files US patent application for antifungal nail lacquer

Aug. 26, 1999

BioCryst reports initial phase II results from worldwide influenza collaboration

Aug. 25, 1999

Antimycotic agents, triazole derivatives prepared and evaluated by Japanese lab

Aug. 25, 1999

More antiviral agents against CMV discovered at Bayer

Aug. 25, 1999

King completes acquisition from Lilly of U.S. rights to Lorabid

Aug. 25, 1999

Antifungal agent DuP-991 available for licensing from BTG

Aug. 25, 1999

Bayer research yields new anti-CMV compounds

Aug. 24, 1999

Millennium delivers eighth antibacterial drug target to Wyeth-Ayerst

Aug. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...